Yu Tang is the Vice President and Head of CMC at Syncromune, where they manage the CMC organization for process and product development, GMP manufacturing, and regulatory filing. They have over 14 years of extensive experience in the development and manufacture of a variety of biologic therapeutics, with expertise in both early-stage and late-stage drug product and substance development. Yu previously held significant roles at Syndax Pharmaceuticals, Eli Lilly and Company, Novartis, Shire, and Seattle Genetics, contributing to successful drug formulation and CMC strategy. Yu earned a Ph.D. in Pharmaceutical Sciences from North Dakota State University and a B.S. in Clinical Pharmacy from West China School of Pharmacy, Sichuan University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices